Schedules of Controlled Substances: Placement of Brivaracetam Into Schedule V
scheduling · Rule · Interim final rule, with request for comments. · Published 2016-05-12 · 81 FR 29487
Document
Document number
2016-11245
Federal Register citation
81 FR 29487
Type
Rule
Action
Interim final rule, with request for comments.
Category
scheduling
Publication date
2016-05-12
Abstract
The Drug Enforcement Administration is placing the substance brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (also referred to as BRV; UCB-34714; Briviact) (including its salts) into schedule V of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act, as revised by the Improving Regulatory Transparency for New Medical Therapies Act which was signed into law on November 25, 2015.